Targeting the microbiota-gut-brain axis in neurodegeneration: Zebrafish-based investigations

Bharti Verma1, Rahul Kumar1, Avani Sharma1

  • 1SRM Modinagar College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Ghaziabad, India.

Insights

The microbiota-gut-brain axis (MGBA) is vital for brain health. Disruptions in this pathway are linked to neurological disorders like Alzheimer's and Parkinson's disease.

Area of Science:

  • Neuroscience
  • Microbiology
  • Gastroenterology

Background:

  • The microbiota-gut-brain axis (MGBA) is a bidirectional communication pathway between the gut microbiome and the central nervous system (CNS).
  • MGBA plays a critical role in brain and gut development and function.
  • Dysfunction in MGBA is associated with the development of neurological disorders.

Purpose of the Study:

  • To review the molecular and neurobehavioral properties of Zebrafish as a model for studying MGBA.
  • To discuss current discoveries in humans regarding MGBA's role in neuropathology.
  • To highlight the potential of Zebrafish models combined with in vivo imaging for understanding gut-brain interactions in neurological diseases.

Main Methods:

  • Comprehensive literature search of PubMed, Scopus, Web of Science, and Google Scholar.
  • Review of molecular and neurobehavioral properties of Zebrafish.
  • Analysis of existing research on MGBA in human neurological disorders.

Main Results:

  • Gut dysbiosis and metabolites can lead to gastrointestinal inflammation, increased pro-inflammatory cytokines, and immune cell infiltration into the brain.
  • These processes can result in neuroinflammation, neuronal defects, and behavioral changes.
  • Zebrafish offer a valuable genetic model for investigating MGBA mechanisms in neurological conditions.

Conclusions:

  • The MGBA is a critical factor in maintaining neurological health.
  • Imbalances in the gut microbiome contribute to neuroinflammation and neurological disorders.
  • Zebrafish present a promising model for elucidating MGBA's role in diseases such as Alzheimer's, Parkinson's, and autism spectrum disorder.